# Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe

> **NCT02772640** · PHASE4 · COMPLETED · sponsor: **Collegium Medicum w Bydgoszczy** · enrollment: 83 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Rosuvastatin and Ezetimibe morning or evening administration

## Key facts

- **NCT ID:** NCT02772640
- **Lead sponsor:** Collegium Medicum w Bydgoszczy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2019-01
- **Final completion:** 2020-05
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2021-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02772640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02772640, "Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02772640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*